Arcus Biosciences (RCUS) Consolidated Net Income (2017 - 2025)
Historic Consolidated Net Income for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$135.0 million.
- Arcus Biosciences' Consolidated Net Income fell 4673.91% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$341.0 million, marking a year-over-year decrease of 2629.63%. This contributed to the annual value of -$283.0 million for FY2024, which is 781.76% up from last year.
- Arcus Biosciences' Consolidated Net Income amounted to -$135.0 million in Q3 2025, which was down 4673.91% from -$112.0 million recorded in Q1 2025.
- Over the past 5 years, Arcus Biosciences' Consolidated Net Income peaked at $279.5 million during Q4 2021, and registered a low of -$135.0 million during Q3 2025.
- Moreover, its 5-year median value for Consolidated Net Income was -$75.5 million (2021), whereas its average is -$58.4 million.
- Within the past 5 years, the most significant YoY rise in Arcus Biosciences' Consolidated Net Income was 63762.48% (2021), while the steepest drop was 437963.78% (2021).
- Arcus Biosciences' Consolidated Net Income (Quarter) stood at $279.5 million in 2021, then plummeted by 123.97% to -$67.0 million in 2022, then dropped by 20.9% to -$81.0 million in 2023, then fell by 16.05% to -$94.0 million in 2024, then tumbled by 43.62% to -$135.0 million in 2025.
- Its last three reported values are -$135.0 million in Q3 2025, -$112.0 million for Q1 2025, and -$94.0 million during Q4 2024.